Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Digital Mammography Under RSNA Spotlight As FDA Panel Meeting Nears

This article was originally published in The Gray Sheet

Executive Summary

Disagreement over interpretations of full-field digital mammography versus conventional film screen mammography images are primarily the result of differences in physician approaches to patient management, researchers from Northwestern University Medical School told attendees of the Radiological Society of North America conference Dec. 1 in Chicago.

You may also be interested in...



PMA May Be Least Burdensome Path For Digital Mammography - Feigal

Trex Medical expects to meet with FDA within the next two weeks to determine the next step in its long-sought pursuit of commercial go-ahead for its full-field digital mammography system, the company says.

Trex' Full-Field Digital Mammography 510(k) Considered Withdrawn - FDA

Trex Medical's pending 510(k) submission for its full-field digital mammography system is now considered "withdrawn" by FDA since the agency "was unable to determine substantial equivalence with analog, or 'film screen,' mammography" based on data submitted by the firm, Trex states in a Dec. 17 release.

ICER Partnering With Aetion To Scale Up Use Of RWE In Value Assessments

Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.

UsernamePublicRestriction

Register

MT012665

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel